Tapewire

Nasdaq · USD

RGNX

REGENXBIO Inc.

Export transactions ↓
Tapewire entity
2211
SEC CIK
0001590877
Parsed reports
367

Last 12 months

Inside the activity.

2 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202601
Jun 202601
Jul 202602
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 31, 2024 Filed Jun 4, 2024 20:43 UTC GrantCommon Stock 4,790 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004655 · primarydocument.xml · nonDerivative · entry 1

MIGAUSKY GEORGE V · CIK 0001134365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,286

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:43 UTC GrantStock Options (Right to Buy) · Derivative 24,454 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001562180-24-004656 · primarydocument.xml · derivative · entry 2

Zachary Jennifer · CIK 0001737231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,454

Underlying: Common Stock · 24,454 shares

Expires 2034-05-31

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:43 UTC GrantCommon Stock 4,790 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004656 · primarydocument.xml · nonDerivative · entry 1

Zachary Jennifer · CIK 0001737231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,296

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:42 UTC GrantStock Options (Right to Buy) · Derivative 24,454 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001562180-24-004653 · primarydocument.xml · derivative · entry 2

Glucksmann Alexandra · CIK 0001658390 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,454

Underlying: Common Stock · 24,454 shares

Expires 2034-05-31

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:42 UTC GrantCommon Stock 4,790 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004653 · primarydocument.xml · nonDerivative · entry 1

Glucksmann Alexandra · CIK 0001658390 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,286

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:41 UTC
Fox Allan M.Director
GrantStock Options (Right to Buy) · Derivative 24,454 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001562180-24-004651 · primarydocument.xml · derivative · entry 6

Fox Allan M. · CIK 0001652936 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,454

Underlying: Common Stock · 24,454 shares

Expires 2034-05-31

F3 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:41 UTC
Fox Allan M.Director
GrantCommon Stock 4,790 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004651 · primarydocument.xml · nonDerivative · entry 1

Fox Allan M. · CIK 0001652936 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,286

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:39 UTC GrantStock Options (Right to Buy) · Derivative 24,454 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001562180-24-004649 · primarydocument.xml · derivative · entry 2

STUMP DAVID C · CIK 0001191235 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,454

Underlying: Common Stock · 24,454 shares

Expires 2034-05-31

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:39 UTC GrantCommon Stock 4,790 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004649 · primarydocument.xml · nonDerivative · entry 1

STUMP DAVID C · CIK 0001191235 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,286

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:42 UTC GrantStock Options (Right to Buy) · Derivative 24,454 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001562180-24-004654 · primarydocument.xml · derivative · entry 2

KARABELAS ARGERIS N · CIK 0001191229 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,454

Underlying: Common Stock · 24,454 shares

Expires 2034-05-31

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:42 UTC GrantCommon Stock 4,790 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004654 · primarydocument.xml · nonDerivative · entry 1

KARABELAS ARGERIS N · CIK 0001191229 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,286

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:40 UTC
Tasse DanielDirector
GrantStock Options (Right to Buy) · Derivative 24,454 $0.00 Strike: $14.35 $0.00
Disclosure

SEC source: 0001562180-24-004650 · primarydocument.xml · derivative · entry 2

Tasse Daniel · CIK 0001502785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,454

Underlying: Common Stock · 24,454 shares

Expires 2034-05-31

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:40 UTC
Tasse DanielDirector
GrantCommon Stock 4,790 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-004650 · primarydocument.xml · nonDerivative · entry 1

Tasse Daniel · CIK 0001502785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,286

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer.

Read SEC document
May 14, 2024 Filed May 16, 2024 21:06 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionStock Options (Right to Buy) · Derivative 15,000 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-24-004104 · primarydocument.xml · derivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 81,354

Underlying: Common Stock · 15,000 shares

Expires 2025-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, which expires on May 19, 2025, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
May 14, 2024 Filed May 16, 2024 21:06 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 15,000 $15.81 $237,222.00
Disclosure

SEC source: 0001562180-24-004104 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 408,035

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.59 to $16.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 14, 2024 Filed May 16, 2024 21:06 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 15,000 $3.76 $56,400.00
Disclosure

SEC source: 0001562180-24-004104 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 423,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:05 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionStock Options (Right to Buy) · Derivative 15,000 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-24-003452 · primarydocument.xml · derivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,354

Underlying: Common Stock · 15,000 shares

Expires 2025-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, which expires on May 19, 2025, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:05 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 15,000 $18.19 $272,871.00
Disclosure

SEC source: 0001562180-24-003452 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 408,035

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $17.82 to $18.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 21:05 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 15,000 $3.76 $56,400.00
Disclosure

SEC source: 0001562180-24-003452 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 423,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 19, 2024 Filed Mar 21, 2024 17:20 UTC
Vasista VittalChief Financial Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 20,041 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-24-002907 · primarydocument.xml · derivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,041 shares

Expires 2025-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
March 19, 2024 Filed Mar 21, 2024 17:20 UTC
Vasista VittalChief Financial Officer
Exercise / conversionCommon Stock 20,041 $3.76 $75,354.16
Disclosure

SEC source: 0001562180-24-002907 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,534

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 14, 2024 Filed Mar 18, 2024 21:03 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionStock Options (Right to Buy) · Derivative 15,000 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-24-002771 · primarydocument.xml · derivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,354

Underlying: Common Stock · 15,000 shares

Expires 2025-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, which expires on May 19, 2025, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
March 14, 2024 Filed Mar 18, 2024 21:03 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 15,000 $21.86 $327,942.00
Disclosure

SEC source: 0001562180-24-002771 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 408,035

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $21.60 to $22.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 14, 2024 Filed Mar 18, 2024 21:03 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 15,000 $3.76 $56,400.00
Disclosure

SEC source: 0001562180-24-002771 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 423,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:05 UTC
PAKOLA STEVEChief Medical Officer
Exercise / conversionStock Options (Right to Buy) · Derivative 12,878 $0.00 Strike: $22.25 $0.00
Disclosure

SEC source: 0001562180-24-002430 · primarydocument.xml · derivative · entry 3

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,277

Underlying: Common Stock · 12,878 shares

Expires 2033-01-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 44,155 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2024, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:05 UTC
PAKOLA STEVEChief Medical Officer
SaleCommon Stock 12,878 $28.36 $365,220.08
Disclosure

SEC source: 0001562180-24-002430 · primarydocument.xml · nonDerivative · entry 2

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,192

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:05 UTC
PAKOLA STEVEChief Medical Officer
Exercise / conversionCommon Stock 12,878 $22.25 $286,535.50
Disclosure

SEC source: 0001562180-24-002430 · primarydocument.xml · nonDerivative · entry 1

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,070

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 23:28 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionStock Options (Right to Buy) · Derivative 15,000 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-24-001395 · primarydocument.xml · derivative · entry 4

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 126,354

Underlying: Common Stock · 15,000 shares

Expires 2025-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 275,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2016, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 23:28 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 10,348 $16.88 $174,722.88
Disclosure

SEC source: 0001562180-24-001395 · primarydocument.xml · nonDerivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 408,035

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $16.78 to $17.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 23:28 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 4,652 $16.47 $76,625.88
Disclosure

SEC source: 0001562180-24-001395 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 418,383

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.78 to $16.77. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 14, 2024 Filed Feb 16, 2024 23:28 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 15,000 $3.76 $56,400.00
Disclosure

SEC source: 0001562180-24-001395 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 423,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 23:39 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionStock Options (Right to Buy) · Derivative 45,000 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-24-000544 · primarydocument.xml · derivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 141,354

Underlying: Common Stock · 45,000 shares

Expires 2025-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 45,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 19, 2015, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 23:39 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 45,000 $15.18 $682,992.00
Disclosure

SEC source: 0001562180-24-000544 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 408,035

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $14.52 to $15.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 16, 2024 Filed Jan 18, 2024 23:39 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 45,000 $3.76 $169,200.00
Disclosure

SEC source: 0001562180-24-000544 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 453,035

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 03, 2024 Filed Jan 4, 2024 21:23 UTC
PAKOLA STEVEChief Medical Officer
SaleCommon Stock 17,237 $17.39 $299,789.35
Disclosure

SEC source: 0001562180-24-000252 · primarydocument.xml · nonDerivative · entry 3

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 107,192

F3 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: This transaction was executed in multiple trades at prices ranging from $17.05 to $17.61. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:23 UTC
PAKOLA STEVEChief Medical Officer
GrantStock Options (Right to buy) · Derivative 50,875 $0.00 Strike: $18.34 $0.00
Disclosure

SEC source: 0001562180-24-000252 · primarydocument.xml · derivative · entry 4

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,875

Underlying: Common Stock · 50,875 shares

Expires 2034-01-02

F5 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:23 UTC
PAKOLA STEVEChief Medical Officer
GrantCommon Stock 32,051 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000252 · primarydocument.xml · nonDerivative · entry 2

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,429

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:23 UTC
PAKOLA STEVEChief Medical Officer
Tax withholdingCommon Stock 10,385 $17.95 $186,410.75
Disclosure

SEC source: 0001562180-24-000252 · primarydocument.xml · nonDerivative · entry 1

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 92,378

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 16:22 UTC
Danos OlivierChief Scientific Officer
GrantStock Options (Right to buy) · Derivative 61,050 $0.00 Strike: $18.34 $0.00
Disclosure

SEC source: 0001562180-24-000249 · primarydocument.xml · derivative · entry 5

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,050

Underlying: Common Stock · 61,050 shares

Expires 2034-01-02

F7 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 16:22 UTC
Danos OlivierChief Scientific Officer
GrantCommon Stock 38,462 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000249 · primarydocument.xml · nonDerivative · entry 4

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,853

F6 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 16:22 UTC
Danos OlivierChief Scientific Officer
Tax withholdingCommon Stock 8,410 $17.95 $150,959.50
Disclosure

SEC source: 0001562180-24-000249 · primarydocument.xml · nonDerivative · entry 3

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,391

F5 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the Issuer's common stock on December 29, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:07 UTC
Mills Kenneth T.Director · President and CEO
GrantStock Options (Right to buy) · Derivative 305,250 $0.00 Strike: $18.34 $0.00
Disclosure

SEC source: 0001562180-24-000223 · primarydocument.xml · derivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 305,250

Underlying: Common Stock · 305,250 shares

Expires 2034-01-02

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:07 UTC
Mills Kenneth T.Director · President and CEO
GrantCommon Stock 64,103 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000223 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 408,035

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:07 UTC
Mills Kenneth T.Director · President and CEO
Tax withholdingCommon Stock 11,357 $17.95 $203,858.15
Disclosure

SEC source: 0001562180-24-000223 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,932

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 16:17 UTC
Vasista VittalChief Financial Officer
GrantStock Options (Right to buy) · Derivative 76,313 $0.00 Strike: $18.34 $0.00
Disclosure

SEC source: 0001562180-24-000246 · primarydocument.xml · derivative · entry 3

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,313

Underlying: Common Stock · 76,313 shares

Expires 2034-01-02

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 16:17 UTC
Vasista VittalChief Financial Officer
GrantCommon Stock 16,026 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000246 · primarydocument.xml · nonDerivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 226,493

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 16:17 UTC
Vasista VittalChief Financial Officer
Tax withholdingCommon Stock 4,534 $17.95 $81,385.30
Disclosure

SEC source: 0001562180-24-000246 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 210,467

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:34 UTC
Simpson CurranChief Oper. & Tech. Officer
GrantStock Options (Right to buy) · Derivative 61,050 $0.00 Strike: $18.34 $0.00
Disclosure

SEC source: 0001562180-24-000257 · primarydocument.xml · derivative · entry 3

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,050

Underlying: Common Stock · 61,050 shares

Expires 2034-01-02

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:34 UTC
Simpson CurranChief Oper. & Tech. Officer
GrantCommon Stock 38,462 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000257 · primarydocument.xml · nonDerivative · entry 2

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,327

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:34 UTC
Simpson CurranChief Oper. & Tech. Officer
Tax withholdingCommon Stock 8,120 $17.95 $145,754.00
Disclosure

SEC source: 0001562180-24-000257 · primarydocument.xml · nonDerivative · entry 1

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,865

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.